About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalNorth & South Carolina
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
2,275
By Phase
PHASE3: 2PHASE2: 1NA: 1
By Status
COMPLETED: 4RECRUITING: 2
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07018700Lead Sponsor
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
PHASE3Recruiting
990 participants
Started: Aug 21, 2025 · Completed: Oct 31, 2027
NCT07018713Lead Sponsor
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
PHASE3Recruiting
780 participants
Started: Aug 21, 2025 · Completed: Mar 31, 2028
NCT06091020Lead Sponsor
A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury
PHASE2Completed
123 participants
Started: Nov 22, 2023 · Completed: Jul 4, 2025
NCT06381999Lead Sponsor
Validity and Inter-rater Reliability for Early Recognition of Spasticity Using the Decision Tree Tool
N/ACompleted
73 participants
Started: Oct 27, 2023 · Completed: Feb 26, 2024
NCT05884528Lead Sponsor
Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia
N/ACompleted
270 participants
Started: Jul 8, 2023 · Completed: Jul 31, 2024
Locations (1)
Headquarters
Raleigh, NC, United States
Map
Loading map...